145 related articles for article (PubMed ID: 37436769)
1. Association Between Syncope Trigger Type and Risk of Subsequent Life-Threatening Events in Patients With Long QT Syndrome.
Younis A; Bos JM; Zareba W; Aktas MK; Wilde AAM; Tabaja C; Bodurian C; Tobert KE; McNitt S; Polonsky B; Shimizu W; Ackerman MJ; Goldenberg I
JAMA Cardiol; 2023 Aug; 8(8):775-783. PubMed ID: 37436769
[TBL] [Abstract][Full Text] [Related]
2. Syncope in genotype-negative long QT syndrome family members.
Olde Nordkamp LR; Ruwald MH; Goldenberg I; Wieling W; McNitt S; Polonsky B; Wilde AA; van Dijk N; Moss AJ
Am J Cardiol; 2014 Oct; 114(8):1223-8. PubMed ID: 25173441
[TBL] [Abstract][Full Text] [Related]
3. Risk Prediction in Male Adolescents With Congenital Long QT Syndrome: Implications for Sex-Specific Risk Stratification in Potassium Channel-Mediated Long QT Syndrome.
Bjelic M; Goldenberg I; Younis A; Chen AY; Huang DT; Yoruk A; Aktas MK; Rosero S; Cutter K; McNitt S; Sotoodehnia N; Kudenchuk PJ; Rea TD; Arking DE; Zareba W; Ackerman MJ; Goldenberg I
J Am Heart Assoc; 2024 Feb; 13(3):e028902. PubMed ID: 38240206
[TBL] [Abstract][Full Text] [Related]
4. Beta-blocker efficacy in high-risk patients with the congenital long-QT syndrome types 1 and 2: implications for patient management.
Goldenberg I; Bradley J; Moss A; McNitt S; Polonsky S; Robinson JL; Andrews M; Zareba W;
J Cardiovasc Electrophysiol; 2010 Aug; 21(8):893-901. PubMed ID: 20233272
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of beta-blockers depending on the genotype of congenital long-QT syndrome: A meta-analysis.
Ahn J; Kim HJ; Choi JI; Lee KN; Shim J; Ahn HS; Kim YH
PLoS One; 2017; 12(10):e0185680. PubMed ID: 29059199
[TBL] [Abstract][Full Text] [Related]
6. Clinical aspects of the three major genetic forms of long QT syndrome (LQT1, LQT2, LQT3).
Kutyifa V; Daimee UA; McNitt S; Polonsky B; Lowenstein C; Cutter K; Lopes C; Zareba W; Moss AJ
Ann Noninvasive Electrocardiol; 2018 May; 23(3):e12537. PubMed ID: 29504689
[TBL] [Abstract][Full Text] [Related]
7. Association of Genetic and Clinical Aspects of Congenital Long QT Syndrome With Life-Threatening Arrhythmias in Japanese Patients.
Shimizu W; Makimoto H; Yamagata K; Kamakura T; Wada M; Miyamoto K; Inoue-Yamada Y; Okamura H; Ishibashi K; Noda T; Nagase S; Miyazaki A; Sakaguchi H; Shiraishi I; Makiyama T; Ohno S; Itoh H; Watanabe H; Hayashi K; Yamagishi M; Morita H; Yoshinaga M; Aizawa Y; Kusano K; Miyamoto Y; Kamakura S; Yasuda S; Ogawa H; Tanaka T; Sumitomo N; Hagiwara N; Fukuda K; Ogawa S; Aizawa Y; Makita N; Ohe T; Horie M; Aiba T
JAMA Cardiol; 2019 Mar; 4(3):246-254. PubMed ID: 30758498
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of different beta-blockers in the treatment of long QT syndrome.
Abu-Zeitone A; Peterson DR; Polonsky B; McNitt S; Moss AJ
J Am Coll Cardiol; 2014 Sep; 64(13):1352-8. PubMed ID: 25257637
[TBL] [Abstract][Full Text] [Related]
9. Risk of aborted cardiac arrest or sudden cardiac death during adolescence in the long-QT syndrome.
Hobbs JB; Peterson DR; Moss AJ; McNitt S; Zareba W; Goldenberg I; Qi M; Robinson JL; Sauer AJ; Ackerman MJ; Benhorin J; Kaufman ES; Locati EH; Napolitano C; Priori SG; Towbin JA; Vincent GM; Zhang L
JAMA; 2006 Sep; 296(10):1249-54. PubMed ID: 16968849
[TBL] [Abstract][Full Text] [Related]
10. Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias.
Schwartz PJ; Priori SG; Spazzolini C; Moss AJ; Vincent GM; Napolitano C; Denjoy I; Guicheney P; Breithardt G; Keating MT; Towbin JA; Beggs AH; Brink P; Wilde AA; Toivonen L; Zareba W; Robinson JL; Timothy KW; Corfield V; Wattanasirichaigoon D; Corbett C; Haverkamp W; Schulze-Bahr E; Lehmann MH; Schwartz K; Coumel P; Bloise R
Circulation; 2001 Jan; 103(1):89-95. PubMed ID: 11136691
[TBL] [Abstract][Full Text] [Related]
11. Trigger-specific risk factors and response to therapy in long QT syndrome type 2.
Kim JA; Lopes CM; Moss AJ; McNitt S; Barsheshet A; Robinson JL; Zareba W; Ackerman MJ; Kaufman ES; Towbin JA; Vincent M; Goldenberg I
Heart Rhythm; 2010 Dec; 7(12):1797-805. PubMed ID: 20850565
[TBL] [Abstract][Full Text] [Related]
12. Risk of Cardiac Events Associated With Antidepressant Therapy in Patients With Long QT Syndrome.
Wang M; Szepietowska B; Polonsky B; McNitt S; Moss AJ; Zareba W; Auerbach DS
Am J Cardiol; 2018 Jan; 121(2):182-187. PubMed ID: 29174490
[TBL] [Abstract][Full Text] [Related]
13. Risk of fatal arrhythmic events in long QT syndrome patients after syncope.
Jons C; Moss AJ; Goldenberg I; Liu J; McNitt S; Zareba W; Qi M; Robinson JL
J Am Coll Cardiol; 2010 Feb; 55(8):783-8. PubMed ID: 20170817
[TBL] [Abstract][Full Text] [Related]
14. Modulating effects of age and gender on the clinical course of long QT syndrome by genotype.
Zareba W; Moss AJ; Locati EH; Lehmann MH; Peterson DR; Hall WJ; Schwartz PJ; Vincent GM; Priori SG; Benhorin J; Towbin JA; Robinson JL; Andrews ML; Napolitano C; Timothy K; Zhang L; Medina A;
J Am Coll Cardiol; 2003 Jul; 42(1):103-9. PubMed ID: 12849668
[TBL] [Abstract][Full Text] [Related]
15. Association of long QT syndrome loci and cardiac events among patients treated with beta-blockers.
Priori SG; Napolitano C; Schwartz PJ; Grillo M; Bloise R; Ronchetti E; Moncalvo C; Tulipani C; Veia A; Bottelli G; Nastoli J
JAMA; 2004 Sep; 292(11):1341-4. PubMed ID: 15367556
[TBL] [Abstract][Full Text] [Related]
16. Molecular biology of the long QT syndrome: impact on management.
Priori SG; Napolitano C; Paganini V; Cantù F; Schwartz PJ
Pacing Clin Electrophysiol; 1997 Aug; 20(8 Pt 2):2052-7. PubMed ID: 9272507
[TBL] [Abstract][Full Text] [Related]
17. Risk of syncope in family members who are genotype-negative for a family-associated long-QT syndrome mutation.
Barsheshet A; Moss AJ; McNitt S; Polonsky S; Lopes CM; Zareba W; Robinson JL; Ackerman MJ; Benhorin J; Kaufman ES; Towbin JA; Vincent GM; Qi M; Goldenberg I
Circ Cardiovasc Genet; 2011 Oct; 4(5):491-9. PubMed ID: 21831960
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for aborted cardiac arrest and sudden cardiac death in children with the congenital long-QT syndrome.
Goldenberg I; Moss AJ; Peterson DR; McNitt S; Zareba W; Andrews ML; Robinson JL; Locati EH; Ackerman MJ; Benhorin J; Kaufman ES; Napolitano C; Priori SG; Qi M; Schwartz PJ; Towbin JA; Vincent GM; Zhang L
Circulation; 2008 Apr; 117(17):2184-91. PubMed ID: 18427136
[TBL] [Abstract][Full Text] [Related]
19. Influence of the genotype on the clinical course of the long-QT syndrome. International Long-QT Syndrome Registry Research Group.
Zareba W; Moss AJ; Schwartz PJ; Vincent GM; Robinson JL; Priori SG; Benhorin J; Locati EH; Towbin JA; Keating MT; Lehmann MH; Hall WJ
N Engl J Med; 1998 Oct; 339(14):960-5. PubMed ID: 9753711
[TBL] [Abstract][Full Text] [Related]
20. Catecholamine-induced T-wave lability in congenital long QT syndrome: a novel phenomenon associated with syncope and cardiac arrest.
Nemec J; Hejlik JB; Shen WK; Ackerman MJ
Mayo Clin Proc; 2003 Jan; 78(1):40-50. PubMed ID: 12528876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
